TY - CHAP
T1 - The importance of biofilms in chronic rhinosinusitis
AU - Leid, Jeff G.
AU - Cope, Emily K.
AU - Parmenter, Stacy
AU - Shirtliff, Mark E.
AU - Dowd, Scot
AU - Wolcott, Randall
AU - Basaraba Dvm, Randall
AU - Hunsaker, Darrell
AU - Palmer, James
AU - Cohen, Noam
PY - 2011
Y1 - 2011
N2 - There is mounting evidence that bacterial and possibly fungal biofilms play an important role in the etiology and persistence of Chronic Rhinosinusitis (CRS). CRS affects nearly 16-25% of the US population each year, with billions of dollars of annual healthcare expenditures dedicated to its treatment (Gliklich and Metson 1995). Unfortunately, the recalcitrant nature of the disease, which often exhibits a chronic relapsing course, significantly contributes to these healthcare costs. The reasons for the persistent nature of the disease are likely secondary to a number of underlying pathophysiologic mechanisms. Asthma, allergic rhinitis, Gram-positive and Gram-negative infections, aspirin-sensitive asthma, fungus, osteitis, nasal polyposis, superantigens, and other factors have been implicated as etiologies contributing to the development of CRS.
AB - There is mounting evidence that bacterial and possibly fungal biofilms play an important role in the etiology and persistence of Chronic Rhinosinusitis (CRS). CRS affects nearly 16-25% of the US population each year, with billions of dollars of annual healthcare expenditures dedicated to its treatment (Gliklich and Metson 1995). Unfortunately, the recalcitrant nature of the disease, which often exhibits a chronic relapsing course, significantly contributes to these healthcare costs. The reasons for the persistent nature of the disease are likely secondary to a number of underlying pathophysiologic mechanisms. Asthma, allergic rhinitis, Gram-positive and Gram-negative infections, aspirin-sensitive asthma, fungus, osteitis, nasal polyposis, superantigens, and other factors have been implicated as etiologies contributing to the development of CRS.
UR - http://www.scopus.com/inward/record.url?scp=79960459353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960459353&partnerID=8YFLogxK
U2 - 10.1007/978-1-4419-6084-9_8
DO - 10.1007/978-1-4419-6084-9_8
M3 - Chapter
AN - SCOPUS:79960459353
SN - 9781441960832
SP - 139
EP - 160
BT - Biofilm Infections
PB - Springer New York
ER -